pcr test Archives - The Dark Intelligence Group

TAG:

pcr test

Leveraging Testing Technology To Identify MRSA, C. Difficile

By Joseph Burns | From the Volume XX No. 3 – March 4, 2013 Issue

CEO SUMMARY: Probably the most challenging infections for hospitals to control and reduce are methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff). The laboratory at one New York hospital introduced algorithms to screen for the presence of each i…

November 03, 2014 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXI No. 15 – November 3, 2014 Issue

In response to the Ebola outbreak, the Food and Drug Administration issued an emergency authorization for the use of two rapid tests to detect Ebola. The tests are manufactured by BioFire Defense LLC, a division of BioMerieux. The BioFire Defense Fil…

TriCore Lab Adds Value with Consults, Better TAT

By Joseph Burns | From the Volume XX No. 8 – June 17, 2013 Issue

CEO SUMMARY: Motivated by the goal of delivering more value to clinicians and client hospitals, the lab team at TriCore Reference Laboratories in Albuquerque, New Mexico, is proactively introducing new services. One such initiative is to travel to hospitals to participate in rounds and co…

“Liked the Product–Bought the Company,” BD Acquires HandyLab and Jaguar System

By Robert Michel | From the Volume XVI No. 16 – November 23, 2009 Issue

IT WAS 1979 WHEN VICTOR KIAM jump-started sales of Remington electric razors with his classic, witty ad campaign, “I liked the product so much, I bought the company!” Now the same thing is happening with a benchtop-sized automated system for molecular PCR testing. In this case, it is Bec…

GSK and Abbott Team up For Companion Diagnostic

By Robert Michel | From the Volume XVI No. 14 – October 12, 2009 Issue

CEO SUMMARY: Although GlaxoSmithKline PLC is several years away from having a deliverable product from its Antigen Specific Cancer Immunoassay (ASCI) Program, it has a development deal with Abbott Laboratories to produce a companion diagnostic test for ASCI-based products. The in…

Influenza A Test Is a Help When Screening for H1N1

By Robert Michel | From the Volume XVI No. 8 – June 8, 2009 Issue

CEO SUMMARY: Viracor Laboratories is preparing to handle expanded volumes of influenza testing prior to the start of the next flu season. It will use added instrumentation and expanded working hours to expand capacity. Another strategy is to use influenza A testing as a way to re…

Competition in Rapid Tests Means Value to Labs

By Robert Michel | From the Volume XVI No. 4 – March 16, 2009 Issue

CEO SUMMARY: One of the hottest market segments in in vitro diagnostics (IVD) is rapid testing. However, because labs now often have multiple choices when selecting a rapid test, IVD manufacturers recognize the need to differentiate their products by adding additional features an…

Newspaper Reports Miss on Molecular Technology

By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue

CEO SUMMARY: In reporting on a suspected outbreak of whooping cough (Bordetella pertussis), a national newspaper suggested administrators at Dartmouth Hitchcock Medical Center had placed too much faith in molecular testing. In this exclusive interview, Dartmouth’s Director of Molecular …

Phlebotomist Gibson Steals Patient’s Identity

By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue

CEO SUMMARY: It was a case of a well-liked lab worker acting in rogue fashion to steal and use the identity of a patient to commit financial fraud. Within laboratories, employees in phlebotomy, accessioning, data entry, coding, billing, and collections often have access to sensitive patie…

Focus Technologies Offers SARS Test to Clinicians

By Robert Michel | From the Volume X No. 7 – May 27, 2003 Issue

EARLIER THIS MONTH, Focus Technologies reference laboratories of Cypress, California announced the development of a “first-generation, real-time PCR test” designed to detect the presence of the coronavirus associated with severe acute respiratory syndrome (SARS). “Focus devel…

Volume XXVII No. 9 – June 22, 2020

THE NEWS ON THE SEROLOGICAL TEST FRONT is discouraging, even bleak, as THE DARK REPORT analyzes the outcome of the FDA’s own review of 11 tests previously listed as marketable. Only three tests passed the review, and yet a quality control expert consulted by THE DARK REPORT has dim views of the FDA’s testing operation, leading to even more doubts. Also, health insurers are scraping away at mandated COVID-19 test reimbursements, leaving lab revenues once again at their mercy.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Topics

Visit The Dark Library